Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-200-5 | CAS number: 1312-81-8
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Summary Genotoxicity:
Lanthanum oxide was negative in a standard bacterial gene mutation assay with S. typhimurium TA1535, 1537, 98, 100 and 102 (Sokolowsky 2006) with and without a metabolic activation system. The soluble Lanthanum derivative Lanthanum nitrate hexahydrate was also reported to be negative in a bacterial assay with S. thyphimurium strains TA100, TA1535, TA97 and TA98 (Zeiger et al., 1992), suporting the negative effect of lanthanum ions in this test system Several other mutagenicity studies are available for the lanthanum carbonate. These are considered relevant for lanthanum oxide as well due to the similarly low water solubility of both substances. Lanthanum carbonate was negative in a mammalian gene mutation assay (HPRT-locus) in Chinese Hamster Ovary cells and a bacterial gene mutation assay in TA1535, TA1537, TA1538, TA98, TA100, TA102) and E. coli WP2 uvrA and WP2 uvrA (pkm101) both with and without metabolic activation (Damment et al. 2005). An in vitro cytogenetic assay in Chinese Hamster ovary cells with lanthanum carbonate was equivocal. Apparent positive findings at some concentrations were attributed to cytotoxicity and precipitation of the test substance (Damment et al. 2005).. An in vivo oral mouse bone marrow micronucleus test in CD-1 mice with lanthanum carbonate was negative (non mutagenic) (Damment et al. 2005). Several studies have also been performed with lanthanum chloride. As a the chloride is soluble lanthanum salt these are representative for testing La3+genotoxicity. Lanthanum chloride was negative in a rat bone marrow micronucleus test after intravenous administration and in a rat liver in vivo/ex vivo UDS assay after 28-day repeated intravenous administration (Damment et al. 2005).
From the results of these tests it can be concluded that lanthanum compounds, including lanthanum oxide are not genotoxic and not clastogenic.
Short description of key information:
From available valid in vitro and in vivo data with lanthanum compounds it can be concluded that lanthanum oxide is not genotoxic and not clatogenic.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Due to the negative results in in vitro and in vivo genotoxicity studies with lanthanum compounds no classification for genotoxicity is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
